Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 2025-12-12 00:21
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten 2025-12-11 23:57
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO 2025-12-11 14:12
Hakka Medicine: From Millennia of Heritage to Modern Industrialization - A Health Path Connecting the World 2025-12-11 08:00
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration 2025-12-11 03:30
Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006 2025-12-10 22:05
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics 2025-12-10 21:00
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment 2025-12-10 17:15
Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held 2025-12-10 14:20
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs 2025-12-10 09:30
Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights 2025-12-10 08:00
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine 2025-12-09 08:00
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide 2025-12-09 03:11
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium 2025-12-09 03:05
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025 2025-12-08 22:22
Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions 2025-12-08 20:24
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight 2025-12-08 17:40
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder 2025-12-08 15:25
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed 2025-12-08 06:08
/C O R R E C T I O N -- Seegene Inc./ 2025-12-06 00:00